MarginsXMarginsX
Home › Canada › TSXV stocks › ARCH

Arch Biopartners Inc. (TSXV: ARCH)

ARCH trades on the TSX Venture Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.9300
-8.82% on the day
Market cap (C$)
C$56.4M
TMX list, October 31, 2026
Market cap (US$)
US$39.5M
Nano cap at 1.4257 C$/US$
1-year return
-8.8%
-23.8% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for ARCH.V, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerARCH on the TSX Venture Exchange
Yahoo symbolARCH.V
SectorLife Sciences
HeadquartersOntario
Listed2015-02-23
Listing typeOther
Shares outstanding67,933,289
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIKNo SEC filer matched on exact name with a Canadian address or US interlisting
WebsiteNo company website on record

Returns

WindowReturn
1 day-8.8%
1 week+6.9%
1 month+8.1%
3 months-19.1%
6 months+116.3%
Year to date-23.8%
1 year-8.8%
From 52-week high-35.9%
52-week rangeC$0.4100 to C$1.45

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

147 documents in 5 types. Each title links to the document at its source.

Annual financial statements (14)

DocumentTypeFiled
2013 Q4 Year-end Financial Statements
Period Q4 2014
Annual financial statements2014-01-28
2012 Q4 Year-end Financial Statements
Period Q4 2013
Annual financial statements2013-01-29
2011 Q4 Year-end Financial Statements
Period Q4 2011
Annual financial statementsNo date
2022 Q4 Year-end Financial Statements
Period Q4 2022
Annual financial statementsNo date

Interim financial statements (51)

DocumentTypeFiled
2025 Q4 Interim Financial Statements
Period Q4 2025
Interim financial statements2026-10-27
2025 Q2 Interim Financial Statements
Period Q2 2025
Interim financial statements2026-10-27
2025 Q3 Interim Financial Statements
Period Q3 2025
Interim financial statements2026-10-27
2026 Q2 Interim Financial Statements
Period Q2 2026
Interim financial statements2026-10-27

MD&A (63)

DocumentTypeFiled
2023 Q4 Management Discussion and Analysis
Period Q4 2023
MD&A (annual)No date
2013 Q4 Management Discussion and Analysis
Period Q4 2013
MD&A (annual)No date
2018 Q4 Management Discussion and Analysis
Period Q4 2018
MD&A (annual)No date
2022 Q4 Management Discussion and Analysis
Period Q4 2022
MD&A (annual)No date

Material change report (17)

DocumentTypeFiled
2025-11-30 ARCH Material Change ReportMaterial change report2025-11-30
2024-08-07 ARCH Material Change ReportMaterial change report2024-08-07
2020-12-22 ARCH Material Change ReportMaterial change report2020-12-22
2020-07-06 ARCH Material Change ReportMaterial change report2020-07-06

Other (2)

Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

US private placements (SEC Form D)

FiledSecuritiesSoldOfferedFiling
2015-01-22Equity, Option To Acquire, Security To Be AcquiredUS$265KUS$265KSEC EDGAR
2014-08-18Equity, Option To Acquire, Security To Be AcquiredUS$156KUS$156KSEC EDGAR
2014-04-04Equity, Option To Acquire, Security To Be AcquiredUS$140KUS$140KSEC EDGAR
2014-03-06Equity, Option To Acquire, Security To Be AcquiredUS$70KUS$70KSEC EDGAR

Source: SEC EDGAR Form D filings matched on exact issuer name. Amounts are US$ as filed.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
OTCOcumetics Technology Corp.TSXVC$56.2M-9.8%-63.7%
WOLFGrey Wolf Health Corp.TSXVC$57.2M-5.2%+24.1%
AIAINetraMark Holdings Inc.TSXC$54.7M-4.8%-52.0%
TELYTelyRx Holdings Inc.TSXC$64.3M-25.7%Under a year of closes
EKEverkind Wellness Inc.TSXVC$65.0M-27.8%Under a year of closes

The app has the price chart, every filing, private raises and the full peer set for ARCH.

Open in the app